Literature DB >> 22286773

HHV-8-associated multicentric Castleman's disease in HIV-negative patient: a novel therapy for an orphan disease.

Maria M Sbenghe, Emmanuel Besa, Amit Mahipal, Alina Dulau Florea, Paul Bray, Jaime Caro.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22286773      PMCID： PMC3267815          DOI： 10.1634/theoncologist.2011-0226

Source DB:  PubMed          Journal:  Oncologist        ISSN： 1083-7159


× No keyword cloud information.
  7 in total

1.  Effects of bortezomib on pro-inflammatory cytokine levels and transfusion dependency in a patient with multicentric Castleman disease.

Authors:  Georg Hess; Volker Wagner; Andreas Kreft; Claus Peter Heussel; Christoph Huber
Journal:  Br J Haematol       Date:  2006-09       Impact factor: 6.998

2.  Efficacy of bortezomib in refractory form of multicentric Castleman disease associated to poems syndrome (MCD-POEMS variant).

Authors:  Marta Anna Sobas; Natalia Alonso Vence; Jose Diaz Arias; Angeles Bendaña Lopez; Maximo Fraga Rodriguez; Jose Luis Bello Lopez
Journal:  Ann Hematol       Date:  2009-07-28       Impact factor: 3.673

3.  Post-liver transplantation multicentric Castleman disease treated with valganciclovir and weaning of immunosuppression.

Authors:  E J Lim; P Crowley; C A Mitchell; P W Angus
Journal:  Am J Transplant       Date:  2011-01       Impact factor: 8.086

4.  Human herpesvirus 8 encodes a homolog of interleukin-6.

Authors:  F Neipel; J C Albrecht; A Ensser; Y Q Huang; J J Li; A E Friedman-Kien; B Fleckenstein
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

Review 5.  The use of antiviral drugs in the prevention and treatment of Kaposi sarcoma, multicentric Castleman disease and primary effusion lymphoma.

Authors:  C Casper; A Wald
Journal:  Curr Top Microbiol Immunol       Date:  2007       Impact factor: 4.291

6.  Remission of HHV-8 and HIV-associated multicentric Castleman disease with ganciclovir treatment.

Authors:  Corey Casper; W Garrett Nichols; Meei-Li Huang; Lawrence Corey; Anna Wald
Journal:  Blood       Date:  2003-11-13       Impact factor: 22.113

7.  Treatment of multicentric Castleman's Disease accompanying multiple myeloma with bortezomib: a case report.

Authors:  Zhen-gang Yuan; Xiao-yi Dun; Yong-hua Li; Jian Hou
Journal:  J Hematol Oncol       Date:  2009-04-28       Impact factor: 17.388
  7 in total
  4 in total

1.  Patient-reported Outcomes for Multicentric Castleman's Disease in a Randomized, Placebo-controlled Study of Siltuximab.

Authors:  Frits van Rhee; Margaret Rothman; Kai Fai Ho; Sarah Fleming; Raymond S Wong; Alexander Fosså; Angela Dispenzieri; James Cavet; Nikhil Munshi; Jessica Vermeulen; Corey Casper
Journal:  Patient       Date:  2015-04       Impact factor: 3.883

2.  Co-Existence of Multicentric Castleman's Disease and Kaposi's Sarcoma.

Authors:  Reza Yaghoobi; Nader Pazyar; Sadigheh Tavakoli
Journal:  Indian J Dermatol       Date:  2015 May-Jun       Impact factor: 1.494

Review 3.  Update and new approaches in the treatment of Castleman disease.

Authors:  Kah-Lok Chan; Stephen Lade; H Miles Prince; Simon J Harrison
Journal:  J Blood Med       Date:  2016-08-03

Review 4.  Recent Advances in Developing Treatments of Kaposi's Sarcoma Herpesvirus-Related Diseases.

Authors:  Eleonora Naimo; Jasmin Zischke; Thomas F Schulz
Journal:  Viruses       Date:  2021-09-09       Impact factor: 5.048
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.